We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Siemens Healthineers - Laboratory Diagnostics

Download Mobile App

20-Minute POC Test to Diagnose STIs from Rectal and Throat Swabs

By LabMedica International staff writers
Posted on 09 Jun 2023
Print article
Image: Linear dichroism technology provides accurate results and measures multiple targets simultaneously (Photo courtesy of Linear Diagnostics)
Image: Linear dichroism technology provides accurate results and measures multiple targets simultaneously (Photo courtesy of Linear Diagnostics)

Every day, over a million new cases of sexually transmitted infections (STIs) are identified across the globe, making diseases such as gonorrhea and Chlamydia significant health concerns. Although Chlamydia is the most frequently diagnosed STI, gonorrhea cases have also been on the rise. The World Health Organization (WHO) has reported a swift increase in multi-drug resistant gonorrhea, with almost all confirmed treatment failures linked to pharyngeal infections, impacting the throat. Traditional tests involve identifying DNA from swabs or urine samples, which require lab processing and could result in delays from several days to weeks between testing and result delivery. The extraction of DNA from rectal or pharyngeal swabs, however, presents more difficulties Now, a new testing platform technology is being optimized and validated to diagnose STIs from rectal and pharyngeal (throat) swabs.

Linear Diagnostics (Birmingham, UK), a University of Birmingham (Birmingham, UK) spinout, has received funding from the National Institute for Health and Care Research (NIHR, London, UK) to optimize and validate its LDx-CTNG platform technology. This innovative approach utilizes linear dichroism, where a beam of polarized light detects multiple targets from a single sample. The process works by detecting a shift in the plane of polarized light when a target is bound to a detector. Various molecular recognition methods can be used on the detector molecules to measure the target analytes of interest, such as using antibodies to detect antigens or oligonucleotides to capture corresponding target DNA sequences.

Linear Diagnostics' linear dichroism detection technology can identify short, rapidly synthesized DNA strands, enabling the utilization of EXPAR, an ultrafast DNA amplification method. This has drastically reduced the result delivery time compared to traditional PCR and simplified the necessary hardware due to the isothermal nature of EXPAR, which does not require complex heating and cooling cycles. The incorporation of dyes for multiplexing that absorb in the visible light spectrum has facilitated the use of affordable optical components, enabling the device to be miniaturized to a fully portable size. Moreover, the system can be operated using an internal rechargeable battery, eliminating dependence on main power sources or computer access. By pairing linear dichroism with a disposable cartridge and instrument, it is possible to perform simple point-of-care testing. A proof-of-concept study has already indicated that this technology can provide rapid and accurate diagnostic testing.

“For STIs, the rapidity of the testing procedure is key, as patients prefer to get test results quickly and start treatment immediately,” said Brendan Farrell, Chairman of Linear Diagnostics. “We are aiming to produce a testing platform that will meet the WHO stipulations of being easy to use with minimal training, so people can present for testing and collect their treatment in a single visit.”

Related Links:
Linear Diagnostics 
University of Birmingham 

Platinum Supplier
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Gold Supplier
Parainfluenza Virus Test
Near-Patient Testing Platform
One Step Card Test
CerTest Transferrin

Print article


Clinical Chemistry

view channel
Image: The new assays are designed to run on the B•R•A•H•M•S KRYPTOR compact PLUS clinical chemistry analyzer (Photo courtesy of Thermo Fisher)

Breakthrough Immunoassays to Aid in Risk Assessment of Preeclampsia

Preeclampsia is a life-threatening blood pressure condition that can arise during pregnancy and the postpartum phase. This severe pregnancy complication is a primary cause of maternal and fetal mortality... Read more


view channel
Image: The US FDA has cleared HemoScreen point of care CBC for direct capillary sampling (Photo courtesy of PixCell Medical)

Point of Care CBC Analyzer with Direct Capillary Sampling Enhances Ease-of-Use and Testing Throughput

The world’s only 5-part differential Complete Blood Count (CBC) analyzer that is FDA-cleared, CE-marked, and TGA-approved for point-of-care use has now been granted FDA 510(k) clearance for direct capillary... Read more


view channel
Image: Immune cells present long before infection predict flu symptoms (Photo courtesy of Shutterstock.com)

Single Blood Draw to Detect Immune Cells Present Months before Flu Infection Can Predict Symptoms

For decades, if not centuries, scientists have struggled to solve the mystery of why certain individuals fall ill to infections while others remain unaffected. In an impressive development, researchers... Read more


view channel
Image: The rapid diagnostic test could pinpoint the correct antibiotic for infection treatment in under an hour (Photo courtesy of Microplate Dx)

Point-of-Care Device to Reduce Antibiotic Susceptibility Testing Time from Days to Minutes

Antimicrobial resistance (AMR) is a significant global health issue, currently leading to over 1.27 million deaths worldwide each year. By 2050, AMR could be causing up to 10 million deaths annually, surpassing... Read more


view channel
Image: The Tasso+ device has received CE Mark certification (Photo courtesy of Tasso)

Groundbreaking Blood Lancing Device Obtains Microliter Capillary Whole Blood Samples Painlessly

A convenient, virtually pain-free blood lancet that collects whole liquid blood samples has received CE Mark designation, making the patient-centric, high-volume blood collection solution available in... Read more


view channel
Image: A new electrochemical device can quickly and inexpensively identify people at greatest risk for osteoporosis (Photo courtesy of ACS Central Science, 2023)

Electrochemical Device Identifies People at Higher Risk for Osteoporosis Using Single Blood Drop

With the global increase in life expectancy, the incidence of age-related conditions like osteoporosis is increasing. Osteoporosis, affecting around 200 million individuals worldwide, has a higher incidence... Read more


view channel
Image: The global fully automatic electrolyte analyzers market is projected to reach close to USD 0.77 billion by 2032 (Photo courtesy of 123RF)

Global Fully Automatic Electrolyte Analyzers Market Driven by Surge in Demand for Point-of-Care Testing

Fully automatic electrolyte analyzers can measure the levels of electrolytes in various bodily fluids like blood and plasma. Electrolytes are ions that have an electrical charge and are essential for multiple... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.